A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

First, as a monotherapy, where a single dose delivered weight loss similar to Semaglutide. These data showed no loss of ...

Lexaria Bioscience (LEXX) has received lead clinical site human research ethics committee approval that was required before dosing can begin in ...

Doctors from around the world joined forces to study a medication called semaglutide for type 2 diabetes. The research took ...

While semaglutide remains on the shortage list, Novo Nordisk noted last week that the last remaining dose in short supply — the lowest dose of Wegovy — is now listed as available, CNN reported. “We’re ...